Search for: "BRISTOL-MYERS SQUIBB" Results 301 - 320 of 863
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
21 Sep 2016, 8:25 am by jromDLT
Taxol is a chemotherapy that is based on a naturally occurring substance and is produced by Bristol-Myers Squibb (BMS). [read post]
16 Sep 2016, 4:07 am by John Collins
Previously, the Full Court in Bristol-Myers Squibb Company v Apotex Pty Ltd [2015] FCAFC 2 (BMS) upheld Justice Yates’ ruling at first instance that the grant of an ‘exclusive licence’ meant an exclusive licence to undertake all of the activities within the meaning of “exploit” as defined in the Patents Act. [read post]
7 Sep 2016, 12:29 pm by Jim Higgins
The antipsychotic drug Abilify, also known as aripiprazole, is manufactured by Bristol-Myers Squibb Co. and Otsuka Pharmaceutical Co. [read post]
7 Sep 2016, 12:29 pm by Jim Higgins
The antipsychotic drug Abilify, also known as aripiprazole, is manufactured by Bristol-Myers Squibb Co. and Otsuka Pharmaceutical Co. [read post]
2 Sep 2016, 11:45 am by Clay Hodges
The defendant, Bristol-Myers Squibb, sought the dismissal of the claims by the 592 non-Californian plaintiffs. [read post]
2 Sep 2016, 11:45 am by Clay Hodges
The defendant, Bristol-Myers Squibb, sought the dismissal of the claims by the 592 non-Californian plaintiffs. [read post]
30 Aug 2016, 5:45 am by Adam Steinman
Yesterday the California Supreme Court issued a 4-to-3 decision in Bristol-Myers Squibb Company v. [read post]
22 Aug 2016, 12:53 pm by Tom Lamb
To overcome that headwind and broaden the use of their drugs, Johnson & Johnson, Bristol-Myers Squibb, and Pfizer provided funding to Portola Pharmaceuticals so it could develop AndexXa. [read post]
10 Aug 2016, 5:23 pm by Kevin LaCroix
On August 5, 2016, a shareholder filed a derivative lawsuit in New York (New York County) Supreme Court against Bristol-Myers Squibb, as nominal defendant, and the company’s board of directors. [read post]
10 Aug 2016, 2:40 pm by Michael Grossman
Created by the Japanese company Otsuka Pharmaceutical, it is marketed in North America by Otsuka America and their partner company Bristol Myers-Squibb, an enormous biopharmaceutical manufacturer/marketer. [read post]
5 Aug 2016, 1:09 pm by taotiadmin
In 1993, the California Legislature enacted the Insurance Frauds Prevention Act (“IFPA”) in a unique effort to combat rampant insurance… The post Bristol-Myers Squibb Agrees To Pay $30 million To Settle Whistleblower Case Brought Under The California Insurance Fraud Prevention Act (IFPA) appeared first on TZ Legal - Fraud Fighters. [read post]
5 Aug 2016, 8:30 am by Kristen Law Sagafi
This month, after nearly a decade of litigation, Bristol-Myers Squibb agreed to pay $30 million to settle an IFPA lawsuit that was filed in 2007 by three former Bristol-Myers employees. [read post]
4 Aug 2016, 9:24 am by Neumann Law Group
It is Bristol-Myers Squibb’s top-selling drug; it earned the pharmaceutical company $6.4 billion in 2013. [read post]
30 Jun 2016, 12:12 pm by Tom Lamb
Non-clinical studies have demonstrated reversal of all approved NOACs including Daiichi Sankyo's SavaysaTM/Lixiana® (edoxaban), Boehringer Ingelheim's Pradaxa® (dabigatran etexilate), Johnson & Johnson and Bayer's Xarelto® (rivaroxaban), and Bristol-Myers Squibb and Pfizer's Eliquis® (apixaban). [read post]
16 Jun 2016, 2:46 pm by Dr. Shezad Malik
According to a press release from the FDA, between March 2013 and October 2015, the agency received reports of 101 confirmed cases of acute kidney injury, some of which required dialysis and hospitalization, related to Invokana/Invokamet (canagliflozin, Janssen Pharmaceuticals) and Farxiga/Xigduo XR (dapagliflozin, Bristol-Myers Squibb/AstraZeneca). [read post]
10 May 2016, 3:02 pm by Dr. Shezad Malik
One of the most popular treatment for a variety of mental disorders like bipolar disorder, schizophrenia, and depression, Abilify makes billions for Otsuka Pharmaceutical Company and Bristol-Myers Squibb. [read post]
6 May 2016, 12:30 pm
This post is from the non-Reed Smith side of the blog. [read post]